VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.3664
+0.0198 (5.71%)
At close: Oct 30, 2025, 4:00 PM EDT
0.3730
+0.0066 (1.80%)
Pre-market: Oct 31, 2025, 4:32 AM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $9.33 million as of October 30, 2025. Its market cap has decreased by -68.36% in one year.
Market Cap
9.33M
Enterprise Value
-30.29M
1-Year Change
-68.36%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $9.33M, a decrease of -95.94%. That is a compound annual growth rate of -43.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 9.33M | -81.11% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |